miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13

miR-4326 could serve as a prognostic biomarker for TNBC and regulate tumor progression via targeting MED13.

Authors

Institutions

Publication Details

Journal
World Journal of Surgical Oncology
Published
2026-01-27
DOI
https://doi.org/10.1186/s12957-026-04200-1
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13

Weina Wang, Peng Dai, Jun Chu, Jiaqi Liu et al.
World Journal of Surgical Oncology
MicroRNA in disease regulation
article

miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13

Weina Wang, Peng Dai, Jun Chu, Jiaqi Liu, Huihui Zhang, Linna Kong, Xinyu Zhang
article en

Abstract

miR-4326 could serve as a prognostic biomarker for TNBC and regulate tumor progression via targeting MED13.

World Journal of Surgical OncologyVol. 24(1)
Harbin Medical University (CN), Huawei Technologies (China) (CN), Shanxi Provincial Cancer Hospital (CN), Third Affiliated Hospital of Harbin Medical University (CN), Central Hospital of Zibo (CN)
Good health and well-being
Openalex Percentile: Top 77%
MicroRNA in disease regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.